<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><strong>13. Ascites</strong></p><p>Ascites is the accumulation of excess fluid within the peritoneal cavity.</p><p> </p><p><strong>CAUSES</strong></p><ul><li>Portal hypertension secondary to liver cirrhosis</li><li>Renal failure</li><li>Nephrotic syndrome</li><li>Cardiac failure</li><li>Abdominal tuberculosis</li><li>Intra-abdominal or pelvic malignancies</li></ul><p> </p><p><strong>SYMPTOMS</strong></p><ul><li>Abdominal enlargement</li><li>Abdominal discomfort or pain</li><li>Difficulty breathing</li></ul><p> </p><p><strong>SIGNS</strong></p><ul><li>Distended abdomen</li><li>Shifting dullness</li><li>Fluid thrill</li><li>Abdominal tenderness</li><li>Signs relating to the underlying causes (See appropriate section)</li></ul><p> </p><p><strong>INVESTIGATIONS</strong></p><ul><li>FBC</li><li>BUE &amp; Creatinine</li><li>LFTs</li><li>INR</li><li>Urinalysis</li><li>Abdominal-pelvic ultrasound</li><li>Chest X-ray</li><li>Diagnostic paracentesis<ul><li>Appearance and colour</li><li>Gram stain</li><li>Cell count and differential</li><li>Biochemistry e.g. Albumin</li><li>Microscopy, culture (with bedside inoculation of aerobic &amp; an- aerobic blood culture bottles)</li></ul></li><li>Acid fast bacilli</li><li>Cytology</li></ul><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To relieve symptoms</li><li>To identify and manage underlying cause</li></ul><p><strong>Non-pharmacological treatment</strong></p><ul><li>Bed rest</li><li>Salt restriction &lt;2 g/day</li><li>Fluid restriction to &lt;1.5 L/day</li><li>Avoid NSAID-use</li><li>Alcohol abstinence</li><li>Therapeutic paracentesis (sterile abdominal tap) if ascites is tense and/or there is respiratory embarrassment</li></ul><p><strong>Note 2-6</strong></p><p><strong>Removal of up to 5 litres of ascitic fluid without concomitant colloid infusion is a safe short-term option and unlikely to have haemodynamic consequences</strong>.</p><p><strong>Pharmacological treatment</strong></p><p><strong>A.  Control of ascitic fluid accumulation</strong></p><p><strong>1st Line Treatment</strong></p><p>Evidence Rating: [A]</p><p>•  Spironolactone, oral,</p><p><strong><u>Adults</u></strong></p><p>  50-200 mg daily</p><p>  0.3-3 mg/kg daily</p><p><strong>And</strong></p><p>•  Furosemide, oral,</p><p><strong><u>Adults</u></strong></p><p>  20-80 mg daily</p><p><strong><u>Children</u></strong></p><p>  1-2 mg/kg daily</p><p> </p><p><strong>B.  Massive ascites in liver cirrhosis with respiratory embarrassment requiring more than 5 litres of fluid drainage</strong></p><p>1st Line Treatment</p><p>Evidence Rating: [A]</p><p>•Salt-poor human albumin solution, IV, 6-8 g per litre of ascitic fluid drained</p><p> </p><p><strong>REFERRAL CRITERIA</strong></p><p>Patients with the following conditions must be referred to a specialist. Poor response to diuretic therapy or diuretic-refractory ascites, complicated cirrhotic ascites with suspected spontaneous bacterial peritonitis, hepato-renal syndrome, and hepatic encephalopathy.</p><p>Also refer when an underlying cause cannot be identified.</p>
</body>
</html>
